ADCC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients (NCT03874026) | National Cancer Institute, Naples | 2019-09-05 |
| Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells (NCT03554889) | Hangzhou Cancer Hospital | 2018-08-01 |
Track ADCC automatically
Every clearance here is in the API, with alerts when new ones post.